Guangyunxing GHP Full-Life-Cycle Health Management System Files IPO Prospectus

Optimal hypertension management entails continuous blood pressure monitoring and maintaining blood pressure within the normal range. However, in the traditional hospital-based healthcare model, patients can only undergo intermittent blood pressure measurements, a approach that is prone to misdiagnosis by physicians or nurses, or may fail to detect masked hypertension, thereby delaying valuable early treatment opportunities.

The GHP System of Guangyunxing Health Management Group isA Novel Digital Technology for Blood Pressure Monitoring and Hypertension Management,It provides a simple and scientific approach to improving the awareness, treatment, and control rates of hypertension, thereby reducing mortality and complications.

VCBeat Selects New Products Review, Issue 9, featuringWang Yaomin, Chairman of Guangyunxing Health Management GroupPresenting the Guangyunxing GHP Full Lifecycle Health Management System.

Continuously monitoring the wearer’s blood pressure 24 hours a day, 365 days a year, by wearing the Guangyunxing GHP08 Smart Health Watch and using a mobile phone, is the simplest and most scientific method to improve the awareness, treatment, and control rates of hypertension, thereby reducing mortality and complications. Through blood pressure testing and monitoring of hypertensive patients via the GHP platform, precise blood pressure records are established for each patient, providing integrated hypertension intervention and scientific management, thus forming a closed-loop health management system that enhances hypertension awareness, treatment, and control rates while reducing mortality and complications.

This event has invitedWang Yaomin, Chairman of Guangyunxing Health Management GroupAn introduction to Guangyunxing Intelligent Health Management Group, an overview of the GHP Full Life-Cycle Health Management System, and an explanation of its business policies.

Scan the QR code on the poster to add our assistant and reserve your spot for the live broadcast!

Wang Yaomin

Guangyunxing Health Management Group | Chairman

Chairman of China Anti-Aging Science Center Co., Ltd.; Specially Appointed Expert on the Expert Committee of the Senior Talent Information Center, China National Committee on Aging; Vice Chairman of the Presidium of the Chinese Scientists Forum; and Distinguished Individual in Technological Innovation. During his stay in the United States, Mr. Wang Yaomin led his team in the development of Pandakang, which received multiple accolades and FDA certification for its ability to lower total cholesterol (TC), triglycerides (TG), and low-density lipoprotein cholesterol (LDL), while raising high-density lipoprotein (HDL). In 1999, it was honored by the American Health Association as the “Best Product for Preventing Cardiovascular and Cerebrovascular Diseases” and was extensively promoted by the Los Angeles government. Mr. Wang Yaomin himself was consequently awarded distinctions such as “Honorary Citizen of Houston.”

Guangyunxing Health Management Group is a comprehensive intelligent health management corporation. Centered on the “Good Healthcare Practice (GHP)” theory of full-lifecycle health management, the Group is committed to establishing itself as the benchmark for China’s health management industry.

Headquartered in Shenzhen, the Group maintains branch offices in Chaohu (Anhui), Shanghai, Nanjing, Wuhu, Jiangsu, and other cities. It boasts comprehensive advantages across the entire health management industry chain, encompassing: 1. R&D (genetics, stem cells, biopharmaceuticals, medical devices, etc.); 2. Manufacturing; 3. Biopharmaceuticals; 4. Health Check-ups; 5. Genetic Testing; 6. Stem Cell R&D and Applications; 7. Rehabilitation and Wellness Care; 8. Chronic Disease Management; 9. Stem Cell-based Medical Aesthetics; and 10. The China Entrepreneur Health Center. By leveraging genetic testing, stem cell technology, biotechnology, life information management, and traditional Chinese medicine, we provide comprehensive, personalized, and concierge-style health stewardship. Our mission is to restore health to China’s sub-optimal health population, ultimately enabling individuals to achieve health, longevity, dignity, and happiness.

Addressing the most significant health risks facing the Chinese population, we leverage cutting-edge digital technologies, smart wearable devices and products, and big data management platforms to manage individuals in a sub-health state. Our mission is to facilitate their recovery to optimal health by providing targeted solutions for common sub-health issues such as hypertension, hyperlipidemia, hyperglycemia, hyperuricemia, and sleep disorders.

“Artery Select New Product Launch” is a live-streaming program under the “Artery Select” brand, dedicated to supporting medical enterprises in launching innovative products. The program’s mission is: to empower the milestone launch of every innovative medical product.

Scan the QR code to join the group and reserve a spot for the live stream.

(Already added, please inquire proactively)